
Endo gets fentanyl patch rights from Noven
Executive Summary
Transdermal drug delivery company Noven Pharmaceuticals licensed Endo Pharmaceuticals (pain management) US and Canadian rights to its transdermal fentanyl patch, currently in development to treat chronic pain.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Transdermal
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com